Successful treatment of fibrosing cholestatic hepatitis with pegylated interferon, ribavirin and sofosbuvir after a combined kidney-liver transplantation

被引：20

作者：

Delabaudiere, Cyrielle ^{[1
]}

Lavayssiere, Laurence ^{[1
]}

Doerr, Gaelle ^{[1
]}

Muscari, Fabrice ^{[2
,3
]}

Danjoux, Marie ^{[4
]}

Sallusto, Federico ^{[5
]}

Peron, Jean Marie ^{[3
,6
]}

Bureau, Christophe ^{[3
,6
]}

Rostaing, Lionel ^{[1
,3
,7
]}

Izopet, Jacques ^{[3
,7
,8
]}

Kamar, Nassim ^{[1
,3
,7
]}

机构：

[1] CHU Rangueil, Dept Nephrol & Organ Transplantat, F-31059 Toulouse 9, France

[2] Univ Hosp Rangueil, Dept Surg & Liver Transplantat, Toulouse, France

[3] Univ Toulouse 3, F-31062 Toulouse, France

[4] CHU Purpan, Dept Pathol, Toulouse, France

[5] CHU Rangueil, Dept Urol & Kidney Transplantat, F-31059 Toulouse 9, France

[6] CHU Purpan, Dept Hepatol, Federat Digest, Toulouse, France

[7] CHU Purpan, IFR BMT, INSERM, U1043, Toulouse, France

[8] CHU Purpan, Virol Lab, Toulouse, France

来源：

TRANSPLANT INTERNATIONAL | 2015年 / 28卷 / 02期

关键词：

fibrosing cholestatic hepatitis; hepatitis C virus; kidney transplantation; liver transplantation; sofosbuvir; RECIPIENTS; THERAPY; PEGINTERFERON; INFECTION; ALPHA;

D O I：

10.1111/tri.12428

中图分类号：

R61 [外科手术学];

学科分类号：

摘要：

Fibrosing cholestatic hepatitis (FCH) is a classical but rare and severe form of recurrent hepatitis C virus (HCV) after liver transplantation. Classical anti-HCV therapy, that is pegylated-interferon (peg-interferon) and ribavirin, has been shown to have limited efficacy in treating FCH. Herein, we report on the first case of successful use of peg-interferon, ribavirin, plus sofosbuvir to treat HCV-induced FCH in a combined liver-kidney transplant patient. Antiviral therapy was given for 24 weeks. HCV clearance occurred within 4 weeks after starting therapy and was maintained until 4 weeks after the end of therapy. Antiviral tolerance was good. We conclude that the use of sofosbuvir-based anti-HCV therapy can be successfully used to treat FCH after a liver or combined kidney-liver transplantation.

引用

页码：255 / 258

页数：4

共 50 条

[1] Case Report of Successful Treatment of Fibrosing Cholestatic Hepatitis C with Sofosbuvir and Ribavirin after Liver Transplantation
Kim, Brian
Trivedi, Anshu
Thung, Swan N.
Grewal, Priya
SEMINARS IN LIVER DISEASE, 2014, 34 (01) : 108 - 112
[2] Ledipasvir/Sofosbuvir With Ribavirin for the Treatment of Fibrosing Cholestatic Hepatitis C After Liver Transplantation
Everson, Gregory T.
Forns, Xavier
Mutimer, David
Manns, Michael P.
Reddy, K. Rajender
Flamm, Steven L.
Denning, Jill
Arterburn, Sarah
Brandt-Sarif, Theo
Pang, Phil
McHutchison, John G.
Afdhal, Nezam H.
Charlton, Michael R.
Samuel, Didier
Gane, Edward
TRANSPLANTATION, 2015, 99 : 101 - 101
[3] Ledipasvir/Sofosbuvir With Ribavirin for the Treatment of Fibrosing Cholestatic Hepatitis C After Liver Transplantation
Everson, Gregory T.
Forns, Xavier
Mutimer, David
Manns, Michael P.
Reddy, K. Rajender
Flamm, Steven L.
Denning, Jill
Arterburn, Sarah
Brandt-Sarif, Theo S.
Pang, Phil
McHutchison, John G.
Afdhal, Nezam H.
Charlton, Michael R.
Samuel, Didier
Gane, Edward
GASTROENTEROLOGY, 2015, 148 (04) : S1086 - S1087
[4] LEDIPASVIR/SOFOSBUVIR WITH RIBAVIRIN FOR THE TREATMENT OF FIBROSING CHOLESTATIC HEPATITIS C AFTER LIVER TRANSPLANTATION
Mutimer, David
Forns, Xavier
Manns, Michael
Reddy, K. Rajender
Everson, Gregory T.
Flamm, Steven L.
Denning, Jill
Arterburn, Sarah
Brandt-Sarif, Theo
Pang, Phillip S.
Mchutchison, John G.
Afdhal, Nezam
Charlton, Michael
Samuel, Didier
Gane, Edward
TRANSPLANT INTERNATIONAL, 2015, 28 : 235 - 235
[5] LEDIPASVIR/SOFOSBUVIR WITH RIBAVIRIN FOR THE TREATMENT OF FIBROSING CHOLESTATIC HEPATITIS C AFTER LIVER TRANSPLANTATION
Forns, X.
Mutimer, D.
Manns, M.
Reddy, K. R.
Everson, G. T.
Flamm, S. L.
Denning, J.
Arterburn, S.
Brandt-Sarif, T.
Pang, P. S.
McHutchison, J. G.
Afdhal, N.
Charlton, M.
Samuel, D.
Gane, E.
JOURNAL OF HEPATOLOGY, 2015, 62 : S623 - S623
[6] Successful Treatment of Fibrosing Cholestatic Hepatitis After Liver Transplantation
Cimsit, B.
Assis, D.
Caldwell, C.
Arvelakis, A.
Taddei, T.
Kulkarni, S.
Schilsky, M.
Emre, S.
TRANSPLANTATION PROCEEDINGS, 2011, 43 (03) : 905 - 908
[7] Successful Treatment of Fibrosing Cholestatic Hepatitis after Liver Transplantation.
Assis, David N.
Cimset, Bayindir
Caldwell, Cary
Arvelakis, Antonios
Taddei, Tamar
Kulkarni, Sanjay
Schilsky, Michael
Emre, Sukru
AMERICAN JOURNAL OF TRANSPLANTATION, 2010, 10 : 264 - 264
[8] Amelioration of Fibrosing Cholestatic Hepatitis after Stopping Pegylated Interferon and Ribavirin Therapy after Re-Transplantation for the Hepatitis C Liver Failure
Kang, Koo Jeong
Kim, Yong Hoon
Kim, Hyung Tae
Cho, Won Hyun
Hwang, Jae Seok
LIVER TRANSPLANTATION, 2010, 16 (06) : S181 - S181
[9] Sofosbuvir and Simeprevir for the Treatment of Recurrent Hepatitis C with Fibrosing Cholestatic Hepatitis after Liver Transplantation
Issa, D.
Eghtesad, B.
Zein, N. N.
Yerian, L.
Cruise, M.
Alkhouri, N.
Adams, R.
Hanouneh, I. A.
INTERNATIONAL JOURNAL OF ORGAN TRANSPLANTATION MEDICINE, 2016, 7 (01): : 38 - 45
[10] Successful Treatment of Fibrosing Cholestatic Hepatitis with Daclatasvir and Asunaprevir after Liver Transplantation
Park, J. -I.
Jung, B. -H.
TRANSPLANTATION, 2017, 101 (05) : 291 - 291

← 1 2 3 4 5 →